Topic - Vivus Inc.

Related Stories

This product image provided by Vivus Pharmaceuticals Inc. shows bottles of Qsymia, the company's anti-obesity drug. (Associated Press/Vivus Pharmaceuticals Inc.)

Highly anticipated weight-loss pill wins approval

By Matthew Perrone - Associated Press

Highly anticipated weight-loss pill wins approval

By MATTHEW PERRONE - Associated Press

FDA approves highly anticipated weight-loss pill

By MATTHEW PERRONE - Associated Press

FDA raises safety concerns for Vivus diet pill

By MATTHEW PERRONE - Associated Press

FDA panel recommends approval for Contrave

By The Associated Press - Associated Press

FDA panel recommends approval for Contrave

By The Associated Press - Associated Press

FDA panel rejects experimental weight loss pill

By MATTHEW PERRONE - Associated Press

FDA to review first of 3 new weight loss drugs

By MATTHEW PERRONE - Associated Press

FDA to review first of 3 new weight loss drugs

By MATTHEW PERRONE - Associated Press